미세결실 프로브 시장 규모, 점유율, 성장 분석 : 프로브 종류별, 용도별, 대상 증후군별, 최종사용자별, 기술별, 지역별 - 업계 예측(2026-2033년)

Global Microdeletion Probes Market size was valued at USD 486.9 Million in 2024 and is poised to grow from USD 528.77 Million in 2025 to USD 1023.08 Million by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The microdeletion probes market is experiencing significant growth due to enhanced regulatory approvals for broad genetic testing, which streamline reimbursement processes and promote clinical integration. Recommendations from regulatory agencies for including microdeletion screenings in newborn panels encourage hospitals to invest in validated testing kits, prompting manufacturers to expedite product development. This creates a positive feedback loop, increasing the accessibility of prenatal diagnostics, including non-invasive tests that identify conditions like DiGeorge syndrome, thereby improving perinatal care. Furthermore, the application of these probes in oncology labs for detecting tumor deletions enhances personalized medicine by predicting responses to targeted therapies. This expansion opens up new revenue streams and broadens market presence in specialized clinics worldwide, incentivizing further investment into the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microdeletion Probes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microdeletion Probes Market Segments Analysis

Global microdeletion probes market is segmented by probe type, application, target syndrome, end user, technology and region. Based on probe type, the market is segmented into FISH probes, microarray probes and PCR-based probes. Based on application, the market is segmented into prenatal testing, postnatal genetic testing, oncology and research. Based on target syndrome, the market is segmented into DiGeorge syndrome, Prader-Willi/Angelman syndrome, Williams syndrome, Cri-du-chat syndrome and others. Based on end user, the market is segmented into clinical laboratories, hospitals and academic & research institutes. Based on technology, the market is segmented into fluorescence in situ hybridization (FISH), chromosomal microarray analysis (CMA) and polymerase chain reaction (PCR). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microdeletion Probes Market

The increasing influx of public and private investments in genetic research is driving the demand for advanced molecular tools, particularly microdeletion probes, which significantly improve diagnostic accuracy and efficiency. This financial backing allows laboratories to modernize their infrastructure, train staff, and broaden their research initiatives, fostering an environment that promotes the adoption of these cutting-edge technologies. As a result, vendors are experiencing a surge in interest, leading to accelerated product development and market growth, with wider applications in both research and clinical environments. Additionally, enhanced collaborations between academic institutions and biotechnology companies further extend the influence of these probes in innovative diagnostic processes.

Restraints in the Global Microdeletion Probes Market

The high costs involved in the design, synthesis, and validation of microdeletion probes pose significant financial challenges for many laboratories, especially those with limited budgets. This substantial initial investment discourages smaller research institutions and emerging clinics from adopting these advanced tools within their standard procedures. As a result, the penetration of the market is primarily restricted to well-resourced organizations, hindering wider acceptance. Additionally, concerns about expenses impact purchasing choices, leading some buyers to delay acquisitions or explore more affordable diagnostic alternatives, which ultimately restricts the overall growth of the market. Regulatory compliance further compounds these financial pressures.

Market Trends of the Global Microdeletion Probes Market

The Global Microdeletion Probes market is witnessing a notable trend driven by the rise of precision oncology, with an increasing focus on early diagnosis and personalized treatments for cancer patients. This surge in demand for highly specific microdeletion probes reflects clinicians' need for tools that can identify rare genomic alterations effectively. Consequently, manufacturers are expanding their product offerings to include panels that encompass a wider variety of microdeletion syndromes. This trend facilitates partnerships between biotech companies and diagnostic labs, streamlining product development and creating integrated solutions that enhance healthcare value for providers and patients globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Microdeletion Probes Market Size by Probe Type & CAGR (2026-2033)

• Market Overview
• FISH Probes
• Microarray Probes
• PCR-Based Probes

Global Microdeletion Probes Market Size by Application & CAGR (2026-2033)

• Market Overview
• Prenatal Testing
• Postnatal Genetic Testing
• Oncology
• Research

Global Microdeletion Probes Market Size by Target Syndrome & CAGR (2026-2033)

• Market Overview
• DiGeorge Syndrome
• Prader-Willi/Angelman Syndrome
• Williams Syndrome
• Cri-du-chat Syndrome
• Others

Global Microdeletion Probes Market Size by End User & CAGR (2026-2033)

• Market Overview
• Clinical Laboratories
• Hospitals
• Academic & Research Institutes

Global Microdeletion Probes Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Fluorescence In Situ Hybridization (FISH)
• Chromosomal Microarray Analysis (CMA)
• Polymerase Chain Reaction (PCR)

Global Microdeletion Probes Market Size & CAGR (2026-2033)

• North America (Probe Type, Application, Target Syndrome, End User, Technology)
  • US
  • Canada
• Europe (Probe Type, Application, Target Syndrome, End User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Probe Type, Application, Target Syndrome, End User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Probe Type, Application, Target Syndrome, End User, Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Probe Type, Application, Target Syndrome, End User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Gene Technology IP Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MetaSystems Hard & Software GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytocell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Empire Genomics, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cen4Gen Institute
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genial Genetic Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Instruments, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenDx B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomic Vision S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations